Delving into the Latest Updates on Beijing Sungen Biomedical Technology Co., Ltd. with Synapse

Overview

Tags

Cardiovascular Diseases

Monoclonal antibody

Disease domain score

A glimpse into the focused therapeutic areas

No Data

Technology Platform

Most used technologies in drug development

Targets

Most frequently developed targets

No Data

Top 5 Drug Type	Count

Monoclonal antibody	1

[Translation] A randomized, double-blind, placebo-controlled, single-dose escalation Phase Ib clinical study to evaluate the safety, tolerability, pharmacokinetic characteristics, immunogenicity and preliminary efficacy of SGC001 in Chinese patients with anterior ST-segment elevation myocardial infarction who are scheduled to undergo percutaneous coronary intervention

一项评估SGC001在中国前壁ST段抬高型心肌梗死且计划接受经皮冠状动脉介入治疗的患者中的安全性、耐受性、药代动力学特征、免疫原性和初步疗效的随机、双盲、安慰剂对照、单次给药剂量递增的Ib期临床研究

[Translation]

A randomized, double-blind, placebo-controlled, single-dose escalation Phase Ib clinical study to evaluate the safety, tolerability, pharmacokinetic characteristics, immunogenicity and preliminary efficacy of SGC001 in Chinese patients with anterior ST-segment elevation myocardial infarction who are scheduled to undergo percutaneous coronary intervention

Start Date20 Jan 2025

Sponsor / Collaborator

Beijing Sungen Biomedical Technology Co., Ltd.

CTR20242944

/ RecruitingPhase 1

一项评估SGC001在中国健康成年受试者中的安全性、耐受性、药代动力学、药效动力学和免疫原性的随机、双盲、安慰剂对照、单次给药剂量递增的Ia期临床研究

[Translation] A randomized, double-blind, placebo-controlled, single-dose escalation Phase Ia clinical study to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics and immunogenicity of SGC001 in healthy Chinese adult subjects

评估SGC001在中国健康受试者中单次给药后的安全性和耐受性

[Translation]

To evaluate the safety and tolerability of SGC001 after a single dose in healthy Chinese subjects

Start Date20 Aug 2024

Sponsor / Collaborator

Beijing Sungen Biomedical Technology Co., Ltd.

100 Clinical Results associated with Beijing Sungen Biomedical Technology Co., Ltd.

Login to view more data

0 Patents (Medical) associated with Beijing Sungen Biomedical Technology Co., Ltd.

Login to view more data

100 Deals associated with Beijing Sungen Biomedical Technology Co., Ltd.

Login to view more data

100 Translational Medicine associated with Beijing Sungen Biomedical Technology Co., Ltd.

Login to view more data

Corporation Tree

Boost your research with our corporation tree data.

login

or

view full example data

Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 03 Jul 2025

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

Phase 1

1

Login to view more data